238
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
Date
May 18, 2024
Tracks
Related Products
WHY DO REFLUX PATIENTS PRESS THE BUTTON? FACTORS CONTRIBUTING TO REAL-TIME ESOPHAGEAL SYMPTOM REPORTING IN REFRACTORY REFLUX PATIENTS
Introduction: Physiological and psychological factors contribute to gastroesophageal reflux symptoms. However, most research assesses reflux symptom severity via questionnaires…
SINGLE CELL TRANSCRIPTOMICS REVEAL MAST CELL HETEROGENEITY IN THE HUMAN GUT IN HEALTH AND IBS
BACKGROUND: Mast cells are a major actor in the development of abdominal pain, a hallmark symptom of IBS. We recently showed that a local IgE production triggers mast cell activation leading to food-induced abdominal pain in mice…
MANOMETRIC DIAGNOSIS AND TREATMENT OF RETROGRADE CRICOPHARYNGEAL DYSFUNCTION (R-CPD).
Dysphagia and chest pain are the common symptoms in achalasia. The mechanisms underlying such symptoms are not completely understood. The two symptoms can be triggered by mechanical stimulation via the sensory vagal and spinal afferent nerve fibers…
ACUTE MUCOSAL REACTIONS FOLLOWING FOOD ADMINISTRATION IN IRRITABLE BOWEL SYNDROME ARE NOT ASSOCIATED WITH ALTERED PERMEABILITY OR MAST CELL ACTIVATION EX VIVO
INTRODUCTION: Irritable bowel syndrome (IBS) is a common disorder of gut-brain interaction characterized by abdominal pain associated with bowel movements. Local allergic reactions have been implicated as a mechanism underlying the food-related symptoms often reported by IBS patients…